Furthermore, recent reports have demonstrated that GLUT1 inhibition by use of WZB-117 sensitizes colon and breast cancer cells to conventional chemotherapeutic agents and radiation [25, 26, 27]. The gene discussed is SLC2A1; the disease is breast carcinoma.